To view the PDF file, sign up for a MySharenet subscription.

AFROCENTRIC INVESTMENT CORP LIMITED - Resignation of a director of a subsidiary

Release Date: 17/08/2017 10:09
Code(s): ACT     PDF:  
Wrap Text
Resignation of a director of a subsidiary

AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1988/000570/06)
JSE Code: ACT
ISIN: ZAE000078416
(“AfroCentric” or “the Company”)


RESIGNATION OF A DIRECTOR OF A SUBSIDIARY


The board of directors of AfroCentric (“the Board”) hereby notifies shareholders that Mr Gawie
Erasmus has resigned as an executive director and chief executive officer of Pharmacy Direct
Proprietary Limited with effect from 31 August 2017.

The Board thanks Gawie for his contribution to the Company and wishes him well in his future
role in the IT industry.


Johannesburg
17 August 2017

Sponsor: Sasfin Capital (a member of the Sasfin Group)

Date: 17/08/2017 10:09:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story